Since expression of KOR or MOR was much higher than that of DOR in the HCC tissues and cell lines as described above, agonists specific for KOR and MOR were tested to observe their effects on malignant phenotypes of HCC cells. Here, OPRK1 is linked to hepatocellular carcinoma.